immunotherapy
Ukusebenzisa I-Immunotherapy Ukwelapha Umdlavuza Wesigaba Sakamuva
Isingeniso I-Immunotherapy isiphenduke indlela eyisisekelo ekwelashweni komdlavuza, ikakhulukazi ekwelashweni komdlavuza okusezingeni eliphezulu okukhombise ukusebenza kahle okuncane ngemithi ejwayelekile. Lolu hlelo lokusebenza olusha..
ISIMOTO SEMOTO, Ukwelashwa kweCAR, immunotherapy, Ukwelashwa kwe-T cell
Ingabe I-CAR T-Cell Therapy Iyatholakala E-India?
Wake wazibuza ukuthi ikhona yini indlela enamandla yokulwa nomdlavuza? Manje ake ucabange nje uma ngolunye usuku uthole umsebe wethemba ekulweni kwakho nomdlavuza, ukwelashwa okusebenzisa amandla amasosha omzimba wakho ukukhomba isifo somdlavuza.
2 amashumi ayisikhombisa bio, China, immunotherapy, I-JW Therapeutics, lobambiswano
I-JW Therapeutics kanye ne-2seventy bio Memezela Ubambiswano Lwesu Lokusheshisa Ucwaningo Nokuthuthukiswa Kwe-T-cell-based Immunotherapies
I-SHANGHAI, CHINA kanye ne-CAMBRIDGE, MASSACHUSETTS, US, Okthoba 27, 2022 - I-JW Therapeutics (HKEX: 2126), inkampani ezimele nentsha ye-biotechnology egxile ekuthuthukiseni, ekukhiqizeni nasekuthengiseni i-cell immunotherap.
I-BMS, I-Bristol Myers squibb, immunotherapy, I-melanoma ye-metastatic, nivolumab futhi relatlimab, nivolumab futhi relatlimab-rmbw, I-Opdualag, USFDA
Inhlanganisela yokuqala ye-LAG-3-Blocking antibody, i-Opdualag™ (i-nivolumab ne-relatlimab-rmbw), igunyazwe yi-FDA ezigulini ezinemelanoma engahlanjululwayo noma ye-metastatic.
Ephreli 2022: I-US Food and Drug Administration (i-FDA) igunyaze i-Opdualag (nivolumab ne-relatlimab-rmbw), inhlanganisela yomthamo ongaguquki wezinga lokuqala le-nivolumab kanye ne-relatlimab elawulwa njengokufakwa emthanjeni okukodwa, i-f.
Umthwalo omkhulu wesisu, immunotherapy, KEYTRUDA, I-Pembrolizumab, I-TMB-H
IPembrolizumab igunyazelwe ukusetshenziswa kunoma imuphi umdlavuza onomthwalo omkhulu wokuguquguquka kwesimila
NgoJulayi 2021: I-US Food and Medication Administration (FDA) inwebise izinkomba ze-pembrolizumab (Keytruda), umuthi we-immunotherapy, ukuze ihlanganise noma yimuphi umdlavuza onomthwalo omkhulu wokuguqula (TMB-H). Isigunyazo esisha sithi f..
immunotherapy, Isibindi, Singapore, Ukwelashwa
ISingapore iqale yamukela i-T cell engineering immunotherapy yomdlavuza wesibindi
Agasti 19, 2018: Inkampani yase-Singapore biotechnology i-Lion TCR Pte. Ltd. yagunyazwa yi-Singapore Health Sciences Authority (HSA), futhi umkhiqizo wayo (i-LioCyx ™) ingasetshenziselwa isigaba I/II socwaningo lomtholampilo lokwelapha.
IMOTO NK, immunotherapy
Ukwelashwa kwe-CAR natural killer cell - abalingani baka-MD Anderson noTakeda
I-University of Texas MD MD Anderson Cancer Center kanye ne-Takeda Pharmaceutical Company Limited bangene ekuqondeni okulinganiselwe kanye nemvume yocwaningo ukuze kuthuthukiswe futhi kumakethwe isamukeli se-chimeric antigen esiqondiswe ngombulali wemvelo (CAR.
immunotherapy, Ukwelashwa kwemvelo kokubulala, Ukwelashwa kwe-NK Cell
Ukwelashwa kwe-CAR-NK - I-immunotherapy entsha ekwelapheni umdlavuza
Ukwelashwa kwe-CAR-NK wuhlobo olusha lwe-immunotherapy ekwelapheni umdlavuza. I-Immunotherapy iye yashintsha indlela umdlavuza welashwa ngayo. I-Cancer immunotherapy ihlukaniswe izigaba ezimbili: eyodwa i-immune checkpoint inhibit.
Izidakamizwa, immunotherapy
Umuthi omusha we-immunotherapy kumdlavuza
Ama-immune checkpoint inhibitors ayikilasi lezidakamizwa ezilwa namasosha omzimba ukuze alwe namaseli anomdlavuza. Nokho, iziguli eziningi aziphenduli kulezi zindlela zokwelapha. Kunesigaba esisha somuthi esiqondiswe ku-pr..